タンパク質特性評価・同定市場- 世界の産業規模、シェア、動向、機会、予測、2018年-2028年製品・サービス別、用途別、最終用途別、地域別、競合

タンパク質特性評価・同定市場は、2022年に140億2,000万米ドルと評価され、2028年までにCAGR 13.65%で著しい成長が見込まれています。

この予測は、生物製剤とプロテオミクス分野でタンパク質特性評価・同定がエスカレートしていることに起因しており、プロテオミクス研究への政府による多額の投資が、タンパク質特性評価・同定産業の拡大を後押ししています。さらに、市場の上昇軌道は、新製品導入、共同パートナーシップ、相乗効果のある共同研究など、さまざまな戦略を重視するようになっていることから勢いを増しており、これらすべてが予測期間を通じて大幅な成長を促進する態勢を整えています。

同様に注目すべきは、医薬品領域における研究開発費の急増であり、これは政府からの資金援助と連動しています。このことは、プロテオミクス分野に内在する有望な将来性や、進行中のタンパク質技術の進歩と相まって、予測期間中の市場拡大を推進する極めて重要な力となっています。

その結果、これらの決定要因の累積効果は、タンパク質特性解析および同定市場を力強い成長の軌道へと導き、大きな可能性を引き出し、規定された予測期間内に印象的な景観を確立するように設定されています。

慢性疾患の増加

がん、糖尿病、心血管障害などの慢性疾患は、世界のタンパク質特性評価・同定市場の拡大に大きな影響を与えています。これらの疾患は、タンパク質の発現、翻訳後修飾、相互作用の変化によって区別され、そのすべてが疾患診断、治療介入、医薬品開発のための貴重な洞察をもたらします。タンパク質の特性解析と同定は、疾患特異的なバイオマーカー、潜在的な創薬標的、複雑な経路の識別を含む、慢性疾患の分子基盤を解読する上で極めて重要な役割を果たします。さらに、タンパク質とその相互作用の包括的な理解は、病気の進行や治療に対する耐性の出現を垣間見る上で貴重な情報となります。

個別化医療への需要の高まり

急速なペースで台頭している個別化医療は、患者の遺伝子構成、ライフスタイル、その他の関連要因に基づいたオーダーメイドの治療を提供することを目的とした、急速に急成長している領域です。タンパク質の特性解析と同定という領域に軸足を置く個別化医療は、世界のタンパク質特性評価・同定市場の拡大に大きな影響を及ぼしています。個別化医療が織りなす複雑なタペストリーの中で、タンパク質の特性解析と同定は、疾患特異的なバイオマーカーの発見と、的確に調整された治療介入の策定を支える、不可欠な役割を果たしています。タンパク質とその複雑な相互作用を丹念に解明することにより、研究者たちは、疾患の進行過程に関与する特定のタンパク質を特定し、その後、これらのタンパク質に選択的に関与する標的療法を構築する能力を与えられています。

さらに、質量分析とクロマトグラフィーを含む新しいプロテオミクス技術の推進力は、世界のタンパク質特性評価・同定市場の成長を牽引する力となっています。これらの技術革新は、個別化医療の進化において最も重要な側面である、タンパク質の精査における精度と感度の向上を調査研究者に提供します。

個別化医療に対する需要の高まりは、それ自体の軌道を形成しているだけでなく、世界のタンパク質特性評価・同定市場の拡大を舵取りする重要な要因でもあります。患者の遺伝的体質、ライフスタイル、その他の状況的要素に合わせて独自に成形した治療を提供することを目指す個別化医療は、タンパク質の特性解析と同定にその礎石を見いだし、疾患バイオマーカーをピンポイントで特定し、的を絞った治療法を磨くためのパイプ役を果たしています。さらに、慢性疾患の急増は、革新的で効果的な治療法の需要にスポットライトを当て、タンパク質の特性解析と同定の必要性に拍車をかけています。慢性疾患は、タンパク質発現のシフト、翻訳後修飾、複雑な相互作用によって特徴付けられ、疾患診断、治療介入、医薬のブレークスルーのための極めて重要なデータの貯蔵庫を提供します。

プロテオミクス技術の進歩

世界のタンパク質特性評価・同定市場の拡大は、プロテオミクス技術の進歩に大きく影響されています。これらの技術には、与えられたサンプル内のタンパク質の構成、動作、相互作用を調査するために採用されたツールや手法の配列が含まれます。特に質量分析とクロマトグラフィーに代表される新しいプロテオミクス技術の進化は、研究者に、より高い精度と感度でタンパク質を精査する力を与えました。この進歩により、以前は不可能であったような低濃度のタンパク質の検出や測定が可能になり、タンパク質の特性解析や同定の領域が大幅に広がっています。これらの技術が示す卓越した精度と識別性は、疾患特異的なバイオマーカーをピンポイントで特定し、的を絞った治療介入を行うための前提条件となっています。

プロテオミクス技術の応用により、研究者は、疾患の進展に寄与する明確なタンパク質を特定する手段を与えられ、これらのタンパク質に選択的に関与する治療法の策定を可能にします。プレシジョン・メディシンに基づくこの綿密なアプローチは、患者の予後を大幅に改善し、従来の治療に伴うリスクを軽減する可能性を秘めています。

さらに、医薬品開発の領域におけるプロテオミクス技術の活用も、世界のタンパク質特性評価・同定市場の成長軌道を後押ししています。タンパク質と潜在的な医薬品候補との相互作用を解析することで、研究者は最適な治療可能性を誇る化合物を見極め、その薬理学的特性を改良することができます。

同時に、個別化医療に対する需要の高まりは、世界のタンパク質特性評価・同定市場の拡大に極めて重要な役割を果たしています。プロテオミクス技術の成熟は、疾患特異的バイオマーカーの同定と標的治療アプローチの策定への道を開いており、これらはいずれも個別化医療の基本的な要素を構成しています。

研究開発への注目の高まり

世界のタンパク質特性評価・同定市場の成長軌道を牽引しているのは、研究開発（R&D）努力に起因する推進力であることは否定できないです。タンパク質の特性解析と同定に対する需要が高まるにつれて、より迅速で、より正確で、包括的なタンパク質分析を提供できる独創的な技術と方法論に対する要求が強まっています。研究開発への投資が、タンパク質の特性解析と同定に特化した斬新なツールや技術の出現を促し、市場の能力を高めています。特に、質量分析、タンパク質マイクロアレイ、タンパク質イメージング法などの先駆的なプロテオミクス技術の出現は、タンパク質分析に変革をもたらし、研究者にタンパク質の複雑さに関する前例のない洞察を与えています。

この変革の顕著な例が医薬品開発の分野にあり、プロテオミクスの利用が急速に勢いを増しています。数多くの製薬企業が、プロテオミクス主導の創薬プラットフォームの構築に多額の投資を行っています。さらに、タンパク質の特性解析と同定は、農業、食品科学、環境科学などの多様な分野に大きく進出しています。同時に、学術研究機関は、研究開発イニシアティブに資源を着実に投入し、タンパク質の特性解析と同定の最前線を推し進めています。このような熱心な取り組みにより、新規の調査ツール、技術、手法の出現が促進され、市場の領域が拡大しただけでなく、その成長軌道も著しく豊かになっています。

政府資金の利用可能性

世界のタンパク質特性評価・同定市場は、政府からの資金提供の影響を顕著に受けており、成長の重要な原動力となっています。研究開発の強化、新技術の採用促進、革新的な製品やサービスの迅速な商業化など、さまざまな効果をもたらす触媒としての役割を果たします。政府資金は、研究機関や大学に財政的支援を提供することで、特に重要な役割を果たしています。この支援は学術研究を助け、その結果、タンパク質の特性解析や同定に向けた新しい技術や調査手法の出現に道を開く。このような触媒作用により、新たなバイオマーカーが発見され、多様な疾患に対して的を絞った治療戦略が立てられるようになり、市場の拡大が促進されます。

政府からの資金援助は、画期的な製品やサービスの商業化を推進する上で極めて重要な役割を果たしています。このような財政支援は中小企業（SME）にも及んでおり、製品の構想やマーケティングを容易にしています。このアプローチは、斬新な技術や手法の吸収を容易にするだけでなく、イノベーションの環境を育てる。例えば、政府の資金援助は、新しい質量分析装置やクロマトグラフィー装置の開発を促し、分析コストの削減やタンパク質同定の精度向上に貢献します。

さらに、政府からの資金援助は、学界、産業界、政府機関の間の協力関係やパートナーシップを促進することによって、その影響力を拡大します。これらの戦略的提携は技術革新に拍車をかけ、知識の交換を促進し、先駆的な技術やアプローチの開発と商業化を促進します。タンパク質特性評価・同定市場の壮大なタペストリーの中で、政府による財政支援は、成長を触媒するだけでなく、変革的進歩の出現を促進する織物を複雑に織りなしています。

調査範囲：

本レポートでは、世界のタンパク質特性評価・同定市場を、以下に詳述する業界動向に加えて、以下のカテゴリーに分類しています：

タンパク質特性評価・同定市場：製品・サービス別

• 消耗品
• 機器
• サービス機器

タンパク質特性評価・同定市場：用途別

• 創薬・医薬品開発
• 臨床診断
• その他

タンパク質特性評価・同定市場：最終用途別

• 製薬・バイオテクノロジー企業
• 学術研究機関
• 受託研究機関
• その他

タンパク質特性評価・同定市場：地域別

• 北米
• 米国
• カナダ
• メキシコ
• 欧州
• フランス
• ドイツ
• 英国
• イタリア
• スペイン
• アジア太平洋
• 中国
• インド
• 日本
• 韓国
• オーストラリア
• 南米
• ブラジル
• アルゼンチン
• コロンビア
• 中東＆アフリカ
• 南アフリカ
• サウジアラビア
• アラブ首長国連邦

競合情勢

• 企業プロファイル：世界のタンパク質特性評価および同定市場に存在する主要企業の詳細分析。

利用可能なカスタマイズ：

• TechSci Research社は、所定の市場データを用いて、企業固有のニーズに応じたカスタマイズを提供します。レポートでは以下のカスタマイズが可能です：

企業情報

• 追加市場参入企業（最大5社）の詳細分析とプロファイリング

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界のタンパク質特性評価・同定市場の展望

• 市場規模と予測
  • 金額別
• 市場シェアと予測
  • 製品・サービス別（消耗品、機器、サービス）
  • 用途別（創薬・医薬品開発、臨床診断、その他）
  • エンドユーザー別（製薬・バイオテクノロジー企業、学術研究機関、受託研究機関、その他）
  • 地域別（北米、欧州、アジア太平洋、南米、中東・アフリカ）
  • 企業別（2022年）
• 市場マップ
  • 製品・サービス別
  • アプリケーション別
  • 最終用途別
  • 地域別

第6章 北米のタンパク質特性評価・同定市場の展望

• 市場規模・予測
  • 金額別
• 市場シェアと予測
  • 製品・サービス別
  • アプリケーション別
  • 用途別
  • 国別
• 北米国別分析
  • 米国
  • カナダ
  • メキシコ

第7章 欧州のタンパク質特性評価・同定市場の展望

• 市場規模と予測
  • 金額別
• 市場シェアと予測
  • 製品・サービス別
  • アプリケーション別
  • 用途別
  • 国別
• 欧州国別分析
  • フランス
  • ドイツ
  • 英国
  • イタリア
  • スペイン

第8章 アジア太平洋地域のタンパク質特性評価・同定市場の展望

• 市場規模と予測
  • 金額別
• 市場シェアと予測
  • 製品・サービス別
  • アプリケーション別
  • 用途別
  • 国別
• アジア太平洋地域国別分析
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア

第9章 南米のタンパク質特性評価・同定市場の展望

• 市場規模と予測
  • 金額別
• 市場シェアと予測
  • 製品・サービス別
  • アプリケーション別
  • 用途別
  • 国別
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカのタンパク質特性評価・同定市場の展望

• 市場規模と予測
  • 金額別
• 市場シェアと予測
  • 製品・サービス別
  • 用途別
  • 用途別
  • 国別
• MEA：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の展開
• 合併・買収
• 製品発表

第13章 世界のタンパク質特性評価・同定市場SWOT分析

第14章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第15章 競合情勢

• Business Overview
• Product Offerings
• Recent Developments
• Financials（As Reported）
• Key Personnel
• SWOT Analysis
  • Agilent Technologies
  • Analytik Jena
  • Bio-Rad Laboratories
  • Bruker Corporation
  • Cleaver Scientific
  • Danaher Corporation
  • Eurofins Scientific
  • Horiba
  • Jeol
  • Merck KGaA
  • PerkinElmer Inc
  • Promega Corporation
  • Qiagen NV

第16章 戦略的提言

Protein characterization and Identification market was valued at USD 14.02 Billion in 2022, and is poised for remarkable growth with a CAGR Of 13.65% by 2028. This projection is attributable to the escalating embrace of protein characterization and identification within the biologics and proteomics sectors, complemented by substantial investments by governments in proteomics research, which in turn buttresses the expansion of the protein characterization and identification industry. Furthermore, the market's upward trajectory gains momentum from the increasing emphasis on a spectrum of strategies, including the introduction of novel products, collaborative partnerships, and synergistic collaborations, all of which are poised to foster substantial growth throughout the forecast timeframe.

Equally noteworthy is the surge in research and development expenditure within the pharmaceutical domain, in tandem with governmental funding. This, coupled with the promising prospects inherent in the proteomics field and the ongoing advancements in protein technology, collectively constitute pivotal forces propelling the market's expansion over the forecast duration.

Consequently, the cumulative effect of these determinants is set to steer the protein characterization and identification market toward a trajectory of robust growth, unlocking considerable potential and establishing a striking landscape within the stipulated forecast period.

Increasing prevalence of chronic diseases

Chronic ailments, such as cancer, diabetes, and cardiovascular disorders, wield a substantial influence over the expansion of the Global Protein Characterization and Identification Market. These conditions are distinguished by alterations in protein expression, post-translational modifications, and interactions, all of which proffer valuable insights for disease diagnosis, therapeutic interventions, and pharmaceutical advancement. The process of protein characterization and identification plays a pivotal role in deciphering the molecular underpinnings of chronic ailments, encompassing the discernment of disease-specific biomarkers, potential drug targets, and intricate pathways. Moreover, the comprehensive understanding of proteins and their interplay also furnishes invaluable glimpses into the progression of maladies and the emergence of resistance to treatments.

The escalating prevalence of chronic diseases underscores the heightened demand for protein characterization and identification. According to the World Health Organization (WHO), chronic ailments account for 71% of global fatalities, and this figure is poised to surge in the years ahead. This escalating burden imposed by chronic diseases has triggered a call for novel and efficacious therapies, consequently escalating the requisition for protein characterization and identification.

Furthermore, the burgeoning aspiration for personalized medicine contributes to the burgeoning growth of the global Protein Characterization and Identification market. Personalized medicine strives to deliver tailored treatments based on a patient's genetic composition, lifestyle, and other influencing factors. The process of protein characterization and identification occupies a vital role in sculpting personalized medicine's landscape, offering a platform for the identification of disease-specific biomarkers and the formulation of precisely targeted therapies.

Growing demand for personalized medicine

Emerging at a swift pace, personalized medicine stands as a rapidly burgeoning realm, geared toward furnishing customized treatment grounded in a patient's genetic composition, lifestyle, and other relevant factors. Anchored in the domain of protein characterization and identification, personalized medicine exerts a profound influence on the expansion of the global Protein Characterization and Identification market. In the intricate tapestry of personalized medicine's fabric, protein characterization and identification play an indispensable role, underpinning the discovery of disease-specific biomarkers and the formulation of precisely tailored therapeutic interventions. Through the meticulous unraveling of proteins and their intricate interplays, researchers are endowed with the capability to pinpoint particular proteins entwined in the course of disease progression, subsequently forging targeted therapies that selectively engage with these proteins.

Moreover, the propulsion of novel proteomic technologies, including mass spectrometry and chromatography, constitutes a dynamic force driving the growth of the global Protein Characterization and Identification market. These innovations equip researchers with heightened precision and sensitivity in scrutinizing proteins, an aspect of paramount importance in the evolution of personalized medicine.

The escalating demand for personalized medicine is not only shaping its own trajectory but is also an instrumental factor steering the expansion of the Global Protein Characterization and Identification Market. Aiming to deliver treatments uniquely molded to a patient's genetic constitution, lifestyle, and other contextual elements, personalized medicine finds its cornerstone in protein characterization and identification, serving as a conduit to pinpointing disease biomarkers and honing targeted remedies. Additionally, the surging prevalence of chronic diseases casts a spotlight on the demand for innovative, efficacious therapies, thus fanning the need for protein characterization and identification. Chronic illnesses, hallmarked by shifts in protein expression, post-translational modifications, and intricate interactions, proffer a reservoir of pivotal data for disease diagnosis, therapeutic interventions, and pharmaceutical breakthroughs.

Advancements in proteomic technologies

The expansion of the global Protein Characterization and Identification market has been significantly influenced by the strides achieved in proteomic technologies. These technologies encompass an array of tools and methodologies employed to investigate the configuration, operation, and interplays of proteins within a given sample. The evolution of novel proteomic technologies, notably exemplified by mass spectrometry and chromatography, has empowered researchers to scrutinize proteins with heightened precision and sensitivity. This progression has unleashed the capacity to detect and gauge proteins at markedly lower concentrations than previously feasible, thereby substantially broadening the realm of protein characterization and identification. The exceptional precision and distinctiveness exhibited by these technologies stand as prerequisites for pinpointing disease-specific biomarkers and engineering targeted therapeutic interventions.

Through the application of proteomic technologies, researchers are endowed with the means to pinpoint distinct proteins that contribute to the advancement of diseases, enabling the formulation of therapies that selectively engage with these proteins. This meticulous approach, anchored in precision medicine, bears the potential to profoundly elevate patient outcomes and alleviate the risks associated with conventional treatments.

Moreover, the utilization of proteomic technologies in the domain of drug development has also propelled the growth trajectory of the Global Protein Characterization and Identification Market. By dissecting the interactions between proteins and potential drug candidates, researchers can discern compounds boasting optimal therapeutic potential and refine their pharmacological attributes.

Simultaneously, the surging demand for personalized medicine plays a pivotal role in steering the expansion of the global Protein Characterization and Identification market. The maturation of proteomic technologies has paved the way for the identification of disease-specific biomarkers and the formulation of targeted therapeutic approaches, both of which constitute fundamental components of personalized medicine's landscape.

Increasing focus on research and development

Driving the growth trajectory of the global Protein Characterization and Identification market, the impetus stemming from research and development (R&D) endeavors is undeniable. As the demand for protein characterization and identification escalates, the imperative for inventive technologies and methodologies intensifies, ones capable of delivering swifter, more precise, and all-encompassing protein analyses. The infusion of investments into R&D pursuits has engendered the emergence of novel tools and techniques tailor-made for protein characterization and identification, thereby amplifying the market's capabilities. Notably, the advent of pioneering proteomic technologies such as mass spectrometry, protein microarrays, and protein imaging methods has orchestrated a transformation in protein analysis, granting researchers unprecedented insights into protein intricacies.

A striking illustration of this transformation lies in the sphere of drug development, wherein the employment of proteomics is rapidly gaining momentum. Numerous pharmaceutical enterprises are making substantial investments in the crafting of proteomic-driven drug discovery platforms. Furthermore, protein characterization and identification are making substantial inroads into diverse sectors including agriculture, food science, and environmental science. Concurrently, academic and research institutions are steadfastly channeling resources into R&D initiatives, propelling the frontiers of protein characterization and identification. This fervent engagement has fostered the emergence of novel research tools, technologies, and methodologies that have not only expanded the market's realm but have also markedly enriched its growth trajectory.

Availability of government funding

The global Protein Characterization and Identification market experiences a notable influence from government funding, signifying a significant driver of growth. The availability of funding serves as a catalyst for manifold effects, including the bolstering of research and development endeavors, the facilitation of new technology adoption, and the expeditious commercialization of innovative products and services. Government funding exercises a particularly prominent role by providing financial backing to research institutions and universities. This support aids academic research, which in turn paves the way for the emergence of novel technologies and methodologies geared toward protein characterization and identification. This catalytic process leads to the unearthing of fresh biomarkers and the formulation of targeted therapeutic strategies across a diverse spectrum of ailments, thereby propelling market expansion.

Government funding, in another vein, plays a pivotal part in propelling the commercialization of groundbreaking products and services. Such financial support extends to small and medium-sized enterprises (SMEs), facilitating the conception and marketing of their offerings. This approach not only eases the assimilation of novel technologies and methodologies but also nurtures an environment of innovation. For instance, the backing of government funding can precipitate the creation of new mass spectrometry or chromatography instruments, thereby contributing to reduced analysis costs and heightened precision in protein identification.

Furthermore, government funding extends its influence by fostering collaborations and partnerships among academia, industry, and government entities. These strategic alliances spur innovation, foster the exchange of knowledge, and expedite the development and commercialization of pioneering technologies and approaches. In the grand tapestry of the Protein Characterization and Identification market, the financial support provided by governments intricately weaves a fabric that not only catalyzes growth but also fuels the emergence of transformative advancements.

Market Segmentation

Global Protein Characterization and Identification market can be segmented on the basis of product and service, application, end use and by region. Based on the product and service, the market can be segmented into consumables, instruments, and services. Based on application, the market can be segmented into drug discovery & development, clinical diagnosis, and others. Based on end use, the market is further divided into pharmaceuticals & biotechnology companies, academic research institutes, contract research organizations, and others.

Market Players

Agilent Technologies, Analytik Jena, Bio-Rad Laboratories, Bruker Corporation, Cleaver Scientific, Danaher Corporation, Eurofins Scientific, Horiba, Jeol, Merck KGaA, PerkinElmer Inc, Promega Corporation, Qiagen NV are some of the leading players operating in the global Protein Characterization and Identification market.

Report Scope:

In this report, global Protein Characterization and Identification market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Protein Characterization and Identification Market, By Product and Service:

• Consumables
• Instruments
• Services Instruments

Protein Characterization and Identification Market, By Application:

• Drug Discovery & Development
• Clinical Diagnosis
• Others

Protein Characterization and Identification Market, By End Use:

• Pharmaceuticals & Biotechnology Companies
• Academic Research Institutes
• Contract Research Organizations
• Others

Protein Characterization and Identification Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• Germany
• United Kingdom
• Italy
• Spain
• Asia Pacific
• China
• India
• Japan
• South Korea
• Australia
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE

Competitive Landscape

• Company Profiles: Detailed analysis of the major companies present in the global Protein Characterization and Identification market.

Available Customizations:

• With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Protein Characterization and Identification Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product & Services (Consumables, Instruments, Services)
  • 5.2.2. By Application (Drug Discovery & Development, Clinical Diagnosis, Others)
  • 5.2.3. By End-Use (Pharmaceuticals & Biotechnology Companies, Academic Research Institutes, Contract Research Organizations, Others)
  • 5.2.4. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
  • 5.2.5. By Company (2022)
• 5.3. Market Map
  • 5.3.1 By Product & Services
  • 5.3.2 By Application
  • 5.3.3 By End Use
  • 5.3.4 By Region

6. North America Protein Characterization and Identification Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product & Services (Consumables, Instruments, Services)
  • 6.2.2. By Application (Drug Discovery & Development, Clinical Diagnosis, Others)
  • 6.2.3. By End-Use (Pharmaceuticals & Biotechnology Companies, Academic Research Institutes, Contract Research Organizations, Others)
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Protein Characterization and Identification Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product & Services
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End Use
  • 6.3.2. Canada Protein Characterization and Identification Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product & Services
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End Use
  • 6.3.3. Mexico Protein Characterization and Identification Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product & Services
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End Use

7. Europe Protein Characterization and Identification Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product & Services (Consumables, Instruments, Services)
  • 7.2.2. By Application (Drug Discovery & Development, Clinical Diagnosis, Others)
  • 7.2.3. By End-Use (Pharmaceuticals & Biotechnology Companies, Academic Research Institutes, Contract Research Organizations, Others)
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Protein Characterization and Identification Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product & Services
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End Use
  • 7.3.2. Germany Protein Characterization and Identification Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product & Services
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End Use
  • 7.3.3. United Kingdom Protein Characterization and Identification Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product & Services
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End Use
  • 7.3.4. Italy Protein Characterization and Identification Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product & Services
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By End Use
  • 7.3.5. Spain Protein Characterization and Identification Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product & Services
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By End Use

8. Asia-Pacific Protein Characterization and Identification Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product & Services (Consumables, Instruments, Services)
  • 8.2.2. By Application (Drug Discovery & Development, Clinical Diagnosis, Others)
  • 8.2.3. By End-Use (Pharmaceuticals & Biotechnology Companies, Academic Research Institutes, Contract Research Organizations, Others)
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Protein Characterization and Identification Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product & Services
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End Use
  • 8.3.2. India Protein Characterization and Identification Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product & Services
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End Use
  • 8.3.3. Japan Protein Characterization and Identification Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product & Services
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End Use
  • 8.3.4. South Korea Protein Characterization and Identification Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product & Services
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By End Use
  • 8.3.5. Australia Protein Characterization and Identification Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product & Services
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By End Use

9. South America Protein Characterization and Identification Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product & Services (Consumables, Instruments, Services)
  • 9.2.2. By Application (Drug Discovery & Development, Clinical Diagnosis, Others)
  • 9.2.3. By End-Use (Pharmaceuticals & Biotechnology Companies, Academic Research Institutes, Contract Research Organizations, Others)
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Protein Characterization and Identification Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product & Services
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End Use
  • 9.3.2. Argentina Protein Characterization and Identification Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product & Services
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End Use
  • 9.3.3. Colombia Protein Characterization and Identification Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product & Services
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End Use

10. Middle East and Africa Protein Characterization and Identification Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product & Services (Consumables, Instruments, Services)
  • 10.2.2. By Application (Drug Discovery & Development, Clinical Diagnosis, Others)
  • 10.2.3. By End-Use (Pharmaceuticals & Biotechnology Companies, Academic Research Institutes, Contract Research Organizations, Others)
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Protein Characterization and Identification Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product & Services
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End Use
  • 10.3.2. Saudi Arabia Protein Characterization and Identification Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product & Services
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End Use
  • 10.3.3. UAE Protein Characterization and Identification Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product & Services
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End Use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Global Protein Characterization and Identification Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Business Overview
• 15.2. Product Offerings
• 15.3. Recent Developments
• 15.4. Financials (As Reported)
• 15.5. Key Personnel
• 15.6. SWOT Analysis
  • 15.6.1 Agilent Technologies
  • 15.6.2 Analytik Jena
  • 15.6.3 Bio-Rad Laboratories
  • 15.6.4 Bruker Corporation
  • 15.6.5 Cleaver Scientific
  • 15.6.6 Danaher Corporation
  • 15.6.7 Eurofins Scientific
  • 15.6.8 Horiba
  • 15.6.9 Jeol
  • 15.6.10 Merck KGaA
  • 15.6.11 PerkinElmer Inc
  • 15.6.12 Promega Corporation
  • 15.6.13 Qiagen NV

16. Strategic Recommendations